CTOs on the Move

IMRIS

www.imris.com

 
As the intraoperative imaging expert, IMRIS, Deerfield Imaging measurably improves patient outcomes through planning, product integration and clinical workflow to give surgeons access to diagnostic quality scans in operating room suites. The IMRIS Surgical Theatre, which uniquely transport MR and CT scanners to the patient using ceiling-mounted rails and incorporate other IMRIS imaging technology, are sold globally to hospitals that deliver clinical services to patients in neurosurgical, spinal, interventional and orthopedic markets.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.imris.com
  • 5101 Shady Oak Rd
    Minnetonka, MN USA 55343
  • Phone: 763.203.6300

Executives

Name Title Contact Details

Similar Companies

American Endoscopy Services Inc

American Endoscopy Services Inc is a Nashville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MCD

MCD is a Augusta, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bard Electrophysiology

Bard Electrophysiology is a Lowell, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Meridian Medical Group

Meridian Medical Group is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lucira Health

Lucira Health has developed an at home COVID-19 test kit that delivers PCR quality molecular accuracy in the palm of your hand in 30 minutes or less. Our technology is transforming how we reduce the spread of infectious diseases by bringing accurate, easy-to-use self-testing into the home. This home test kit has not been FDA cleared or approved. This home test kit has been authorized by FDA under EUA. This home test kit has been authorized only for the testing of nasal swabs for detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This home test kit is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of IVDs for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or revoked sooner.